English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
The Washington Post
Patient Daily
| Apr 24, 2026
Washington Post Opinion Editor on 340B drug discounts: 'The program has become a profit-making venture for big businesses'
Trending
+
Pharmaceuticals
Patient Daily
| Apr 19, 2026
Insmed ends skin disease drug development after trial results fall short
+
Pharmaceuticals
Patient Daily
| Apr 23, 2026
Bristol Myers Squibb spinout Beeline Medicines launches with $300 million and five assets
+
Pharmaceuticals
Patient Daily
| Apr 19, 2026
Roche and C4 Therapeutics announce new molecular glue partnership worth up to $1 billion
+
Pharmaceuticals
Patient Daily
| Apr 17, 2026
Replimune faces layoffs and site closures after FDA rejects melanoma drug again
